Application Sponsors
ANDA 208663 | VPI PHARMS INC | |
Marketing Status
Application Products
001 | INJECTABLE;INJECTION | EQ 50MG BASE/VIAL | 0 | ETHACRYNATE SODIUM | ETHACRYNATE SODIUM |
FDA Submissions
UNKNOWN; | ORIG | 1 | AP | 2020-06-09 | STANDARD |
Submissions Property Types
TE Codes
CDER Filings
VPI PHARMS INC
cder:Array
(
[0] => Array
(
[ApplNo] => 208663
[companyName] => VPI PHARMS INC
[docInserts] => ["",""]
[products] => [{"drugName":"ETHACRYNATE SODIUM","activeIngredients":"ETHACRYNATE SODIUM","strength":"EQ 50MG BASE\/VIAL","dosageForm":"INJECTABLE;INJECTION","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"06\/09\/2020","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
[supplements] =>
[actionDate] => 2020-06-09
)
)